EBOS Group

EBOS Group FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of EBOS Group (EBO.NZ) as of Oct 9, 2026 is 96.61 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 171.11 % — a change of -43.54% (lower).

FCF Conversion

96.61 %

YoY

-43.54%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of EBOS Group is 2026 96.61 % . FCF Conversion Rate (FCF/EBITDA) of EBOS Group was 2025 171.11 % . It decreases by -43.54% lower compared to the previous year.

The EBOS Group FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
61.25 AUD
Jan 1, 2020
130.82 AUD
Jan 1, 2021
124.85 AUD
Jan 1, 2022
86.39 AUD
Jan 1, 2023
125.27 AUD
Jan 1, 2024
97.40 AUD
Jan 1, 2025
171.11 AUD
Jan 1, 2026
96.61 AUD
The EBOS Group FCF Conversion history
YEARFCF ConversionYoY
96.61 %-43.54%
171.11 %+75.68%
97.40 %-22.25%
125.27 %+45.01%
86.39 %-30.81%
124.85 %-4.56%
130.82 %+113.58%
61.25 %-18.81%
75.44 %-5.77%
80.05 %-52.27%
167.72 %+50.14%
111.71 %+30.45%
85.64 %—
Access this data via the Eulerpool API

EBOS Group Stock analysis

What does EBOS Group do? The EBOS Group was founded in New Zealand in 2000 and has since grown to become one of the largest healthcare companies in the region. The company's business model is to provide solutions for the healthcare industry, ranging from products for pharmacies, hospitals, and medical practices to healthcare services. The company is divided into several divisions, including healthcare distribution, dental, and healthcare services. The healthcare distribution division focuses on distributing pharmaceutical products, medical devices, and other healthcare items to healthcare facilities. This includes surgical instruments and oncology products. The dental division specializes in selling and distributing dental products, such as instruments for dentists and consumables like gloves, implants, and floss. They also offer services for dentists, including a dental practice built in partnership with another company. The healthcare services division includes the distribution of home care and healthcare products, as well as the rental of medical equipment like wheelchairs and beds. EBOS Group also provides services such as consultation and training for patients, caregivers, and healthcare providers. With a strong emphasis on quality and customer satisfaction, EBOS Group has a successful track record and has acquired and developed several companies in the region. Their products help improve patient health and contribute to reducing healthcare costs. The company plays a vital role in the healthcare products and services market. The EBOS Group's diverse divisions and wide range of products secure its position as an important player in the healthcare industry. EBOS Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EBOS Group stock

FCF Conversion Rate (FCF/EBITDA) of EBOS Group is 96.61 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of EBOS Group changed from 171.11 % to 96.61 %, representing a -43.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) EBOS Group since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s EBOS Group with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — EBOS Group

All Key Metrics — EBOS Group